bpc-157 fda news november 2025 Explained — Plus What Just Changed With the FDA's own advisory committee voted

FDA's own advisory committee voted 8 6 Thursday. BPC 157, on the compounding list now, for ulcerative colitis. FDA staff argued against it, laid out the data gaps, the whole case. Panel overruled them TLDR; no. BPC 157 is a peptide that is not approved by the FDA, but it seems like our good friends over at the supplement industry marketing team have gotten their hands on BPC 157 FDA Approval Status 2026: Clinical Trials The FDA Could Ban These 7 Peptides Forever YouTube

SKU: 26584650763 · From www.asociacionchamorro.org